Jardiance Denied by Insurance? How to Appeal

Jardiance (empagliflozin) has transformed outcomes for patients with type 2 diabetes, heart failure, and chronic kidney disease — yet at $500–$600 per month, it is one of the most frequently denied medications in all three categories. When your insurer requires step therapy through metformin first, demands documentation your cardiologist already provided, or simply labels Jardiance "non-preferred," the denial can feel arbitrary. It often is. Here is how to build a successful appeal using the clinical and legal tools available to you.

Why Insurers Deny Jardiance

Insurance companies deny Jardiance for predictable reasons, most of which can be challenged with targeted evidence.

Metformin step therapy for diabetes. Most plans require documented trial and failure of metformin before approving an SGLT2 inhibitor for glycemic control. However, the 2022 ADA Standards of Medical Care establish that SGLT2 inhibitors with proven cardiovascular or renal benefit are recommended regardless of A1c for patients with T2D and established CVD, HF, or CKD (ADA Standards, Section 9, Class I, Level A). Requiring step therapy through metformin in patients with these conditions is inconsistent with current evidence-based guidelines.

Missing documentation for cardiovascular or heart failure indications. For the heart failure or CKD indication, Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization reviewers commonly deny claims when echocardiogram ejection fraction data, eGFR levels, or albuminuria values are not explicitly included in the PA request — even when your cardiologist or nephrologist has already documented them.

Non-preferred SGLT2 formulary position. If dapagliflozin (Farxiga) is the formulary-preferred SGLT2 inhibitor, insurers may deny Jardiance specifically. A formulary exception is available when clinical evidence supports one agent over another, or when the patient has a documented prior response or intolerance.

Class switching requirements. If a patient is already on another SGLT2 inhibitor, some plans require documented failure of the preferred formulary agent before approving a class switch to empagliflozin.

How to Appeal a Jardiance Denial

Step 1: Identify the Exact Denial Reason

Read your denial letter carefully. Is the denial based on step therapy, missing documentation, formulary position, or medical necessity? Each reason requires a different rebuttal strategy. Under ERISA Section 1133 (29 U.S.C. § 1133) and ACA Section 2719, you are entitled to the full clinical rationale and the specific criteria applied.

Step 2: Gather Your Clinical Documentation

Collect the evidence that directly addresses your denial reason. For diabetes with established CVD, document prior cardiovascular events. For heart failure, provide the most recent echocardiogram showing ejection fraction. For CKD, include lab results showing eGFR (threshold: ≥20 mL/min/1.73m²) and UACR (threshold: ≥200 mg/g). Your prescribing physician should already have these in your chart.

Step 3: Obtain a Physician Letter of Medical Necessity

Ask your cardiologist, endocrinologist, or nephrologist to write a letter explaining why Jardiance is medically necessary for your specific indication. The letter should cite the relevant clinical trial — EMPA-REG OUTCOME (NEJM 2015) for T2D with CVD, EMPEROR-Reduced or EMPEROR-Preserved for heart failure, or EMPA-KIDNEY for CKD — and reference the corresponding guideline recommendation (ADA, ACC/AHA/HFSA, or KDIGO 2022).

Step 4: Cite the Clinical Guidelines Directly

Your appeal must reference the specific guideline language. The 2022 ACC/AHA/HFSA Heart Failure Guidelines give SGLT2 inhibitors a Class I, Level A recommendation for HFrEF (Section 7.3). The 2022 KDIGO CKD Guidelines give SGLT2 inhibitors a Class I recommendation for CKD with eGFR ≥20 mL/min (Section 3.1). The 2022 ADA Standards give a Class I, Level A recommendation for SGLT2 inhibitors in T2D with established CVD, HF, or CKD. Requiring step therapy through an agent without these benefits violates guideline-concordant care.

Step 5: Write and Submit Your Appeal Letter

Your appeal letter should reference your policy number, claim number, and denial date; rebut each denial reason point by point with clinical evidence; cite ACA Section 2719 and your right to External Independent Review: Complete Guide" class="auto-link">external review; and specifically request reversal of the denial with approval of Jardiance at the prescribed dose. Submit via certified mail and through your insurer's member portal. Keep copies with delivery confirmation.

Step 6: Request External Review if the Internal Appeal Fails

Under ACA Section 2719, all non-grandfathered plans must provide access to an independent external review organization (IRO). External reviews of prior authorization denials succeed at rates of 40–60% nationally. Request external review immediately after an internal appeal denial — most states impose a 60-day deadline.

What to Include in Your Jardiance Appeal

• Your denial letter with the specific reason and prior authorization criteria highlighted
• Physician letter of medical necessity citing relevant clinical trials and guideline recommendations
• Lab results: most recent A1c, eGFR, UACR, BNP/NT-proBNP as applicable
• Echocardiogram report documenting ejection fraction (for heart failure indication)
• Documentation of established CVD, HF diagnosis, or CKD stage from physician records
• Relevant guideline citations: ADA 2022, ACC/AHA/HFSA 2022, KDIGO 2022
• Documentation of any prior SGLT2 inhibitor trial or intolerance (for formulary exception)

Fight Back With ClaimBack

Jardiance denials tied to step therapy requirements or missing documentation are among the most reversible prior authorization decisions — particularly when your physician has documented an established cardiovascular, heart failure, or CKD indication. A well-crafted appeal citing EMPA-REG, the EMPEROR trials, and current ADA/ACC/KDIGO guidelines changes the outcome. ClaimBack generates a professional appeal letter in 3 minutes.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal